<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>Molecular Diversity Preservation International</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M619</article-id>
      <article-id pub-id-type="publisher-id">molbank-2009-M619</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Regioselective Alkylation of an Oxonaphthalene-Annelated Pyrrol System</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Spreitzer</surname>
            <given-names>Helmut</given-names>
          </name>
          <xref rid="c1-molbank-2009-M619" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Puschmann</surname>
            <given-names>Christiane</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2009-M619">Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria</aff>
      <author-notes>
        <corresp id="c1-molbank-2009-M619"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>helmut.spreitzer@univie.ac.at</email>; Fax: +43 1 42779556.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>09</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>09</month>
        <year>2009</year>
      </pub-date>
      <volume>2009</volume>
      <issue>3</issue>
      <elocation-id>M619</elocation-id>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>09</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>11</day>
          <month>09</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>09</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license>
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>The regioselective alkylation of an oxonaphthalene-annelated pyrrole system is reported. The regioselectivity of alkylation can be controlled by the selection of the solvent.</p>
      </abstract>
      <kwd-group>
        <kwd>pyrrole</kwd>
        <kwd>alkylation</kwd>
        <kwd>NMR spectroscopy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Nitrogen mustards were the first clinically effective cancer therapeutic agents. Chlorambucil is one of numerous aromatic derivatives of compounds with a nitrogen mustard moiety that have been synthesized. It has been a clinical agent for many years and remains in common use at the present time. The cytotoxic effects are based on the highly active aziridinium cation intermediates arising from the bis(2-chloroethyl)amine moiety [<xref ref-type="bibr" rid="B1-molbank-2009-M619">1</xref>]. In continuation of our department&#x2019;s previous studies in the field of antitumor agents [<xref ref-type="bibr" rid="B2-molbank-2009-M619">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2009-M619">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2009-M619">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2009-M619">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2009-M619">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2009-M619">7</xref>], the pyrrole derivative <bold>1</bold> [<xref ref-type="bibr" rid="B8-molbank-2009-M619">8</xref>] was chosen as an educt for the synthesis of new chlorambucil analogs. Here, we wish to describe the synthesis of the two key intermediates <bold>2a</bold> and <bold>2b</bold> from <bold>1</bold> by regioselective alkylation with the BOC-protected 4-aminobenzyl bromide building block <bold>1a</bold>.</p>
    </sec>
    <sec sec-type="results">
      <title>Results and Discussion</title>
      <p>Starting from pyrrole <bold>1</bold>, the alkylation procedure with <bold>1a</bold>, using NaH as a base in DMF solution afforded only the expected <italic>N</italic>-alkylated product <bold>2a</bold>. On the other hand, use of THF as solvent was found to give selectively access to the C-1 alkylated product <bold>2b</bold>. Based on comparison with previously reported <sup>1</sup>H- and <sup>13</sup>C-NMR data of <bold>1</bold> [<xref ref-type="bibr" rid="B8-molbank-2009-M619">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2009-M619">9</xref>], it was possible to assign to the latter compound (<bold>2b</bold>) the structure of a C-1 alkylated product and to exclude a C-3 alkylated isomer. Thus, a regioselective approach to either <bold>2a</bold> or <bold>2b</bold>, respectively, is possible simply by selection of the appropriate solvent. Since the pyrrole derivative <bold>1</bold> is in conjugation with a strongly electron-withdrawing carbonyl group, previously published studies (see below) on <italic>C</italic>- vs. <italic>N</italic>-alkylation of pyrrole are not fully comparable and thus cannot give a clear explanation of these results: K. Sukata had described increasing C-alkylation vs. <italic>N</italic>-alkylation of pyrrole in protic solvents such as PEG or water, in aprotic solvents such as PEG-ethers <italic>N</italic>-alkylation was preferred [<xref ref-type="bibr" rid="B10-molbank-2009-M619">10</xref>]; D. Y. Chi had developed an ionic liquid methodology for pyrrole to achieve regioselective <italic>N</italic>- and <italic>C</italic>-alkylation, respectively [<xref ref-type="bibr" rid="B11-molbank-2009-M619">11</xref>,<xref ref-type="bibr" rid="B12-molbank-2009-M619">12</xref>].</p>
      <p>After cleavage of the <italic>N</italic>-BOC protecting group, both compounds will now serve as starting materials for the syntheses of new anticancer drugs with a nitrogen mustard moiety, the results will be reported elsewhere.</p>
	  <p><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2009-M619-i001.tif"/></p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec>
        <title>General procedure for the preparation of <italic><bold>2a</bold></italic> or <italic><bold>2b</bold></italic></title>
        <p>A solution of <bold>1</bold> (1.17 g, 5.54 mmol) in 10 mL of dry DMF (for <bold>2a</bold>) or 10 mL of dry THF (for <bold>2b</bold>) was added dropwise under argon to a suspension of NaH (0.20 g of a 60% dispersion in mineral oil; washed with hexane; 8.31 mmol) in 12.5 mL of dry DMF or THF, respectively (see above). After stirring for 0.5 h at 0 &#xB0;C, a solution of <italic>tert</italic>-butyl[4-(bromomethyl)phenyl]carbamate (<bold>1a</bold>) (2.50 g, 8.31 mmol) in dry DMF or THF, respectively (see above), was added. The reaction mixture was heated for 3 h (50 &#xB0;C for DMF or 66 &#xB0;C for THF). The reaction was quenched with water and extracted with ethyl acetate. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The resulting crude product was purified by column chromatography (silica gel, ethyl acetate/light petroleum, 70/30 + 1% triethylamine) to afford 1.31 g (57%) of <bold>2a</bold> or 0.80 g (35%) of <bold>2b</bold>, respectively.</p>
        <p><italic>tert-Butyl[4-[(5,5-dimethyl-4-oxo-4,5-dihydro-2H-benzo[e]isoindol-2-yl)methyl]phenyl]carbamte</italic> (<bold>2a</bold>): M.p. 74-76 &#xB0;C (light petroleum/ethyl acetate). IR (KBr): 3312, 1724, 1650, 1526, 1240, 1155 cm<sup>-1</sup>. MS (EI, 70 eV) <italic>m/z</italic>: 416 (M<sup>+</sup>, 3%), 106 (11), 57 (43), 45 (14) 44 (15), 43 (100), 42 (18), 41 (40). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) &#x3B4; = 9.38 (s<sub>br</sub>, 1H, NH), 7.60 (d, <italic>J</italic> = 1.5 Hz, 1H, 3-H), 7.64-7.42 (m, 5H, 1-H, 6-H, 9-H, 2&#x2019;-H, 6&#x2019;-H), 7.27 (d, <italic>J</italic> = 8.5 Hz, 2H, 3&#x2019;-H, 5&#x2019;-H), 7.18 (m, 2H, 7-H, 8-H), 5.12 (s, 2H, CH<sub>2</sub>), 1.44 (s, 9H, (CH<sub>3</sub>)<sub>3</sub>), 1.35 (s, 6H, (CH<sub>3</sub>)<sub>2</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 50 MHz) &#x3B4; = 196.5 (C-4), 152.7 (COO), 143.4 (C-5a), 139.3 (C-1&#x2019;), 130.8 (C-4&#x2019;), 128.5 (C-3&#x2019;, C-5&#x2019;), 127.1 (C-6), 126.8 (C-9a), 126.4 (C-7), 126.3 (C-8), 124.2 (C-9b), 123.7 (C-3), 122.7 (C-9), 118.2 (C-2&#x2019;, C-6&#x2019;), 117.3 (C-3a), 116.3 (C-1), 79.1 (<underline>C</underline>(CH<sub>3</sub>)<sub>3</sub>), 52.7 (CH<sub>2</sub>N), 46.8 (C-5), 28.1 ((CH<sub>3</sub>)<sub>3</sub>), 27.97 ((CH<sub>3</sub>)<sub>2</sub>). HRMS calcd. for C<sub>26</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub>: 416.2099. Found: 416.2103.</p>
        <p><italic>tert-Butyl[4-[(5,5-dimethyl-4-oxo-4,5-dihydro-2H-benzo[e]isoindol-1-yl)methyl]phenyl]carbamte</italic> (<bold>2b</bold>): M.p. 135-137 &#xB0;C (light petroleum/ethyl acetate). IR (KBr): 3345, 3249, 1697, 1644, 1527, 1238, 1156 cm<sup>&#x2212;1</sup>. MS (EI, 70 eV) <italic>m/z</italic>: 416 (M<sup>+</sup>, 6%), 360 (13), 106 (12), 71 (7), 59 (11), 57 (100), 56 (27), 55 (19). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) &#x3B4; = 11.88 (s<sub>br</sub>, 1H, NH), 9.24 (s, 1H, NH), 7.53-7.44 (m, 3H, 3-H, 6-H, 9-H), 7.36 (d, <italic>J</italic> = 8.5 Hz, 2H, 2&#x2019;-H, 6&#x2019;-H), 7.14-7.04 (m, 4H, 7-H, 8-H, 3&#x2019;-H, 5&#x2019;-H), 4.24 (s, 2H, CH<sub>2</sub>), 1.43 (s, 9H, (CH<sub>3</sub>)<sub>3</sub>), 1.37 (s, 6H, (CH<sub>3</sub>)<sub>2</sub>) . <sup>13</sup>C NMR (CDCl<sub>3</sub>, 200 MHz) &#x3B4; = 197.1 (C-4), 152.8 (COO), 143.6 (C-5a), 137.7 (C-1&#x2019;), 132.2 (C-4&#x2019;), 128.0 (C-3&#x2019;, C-5&#x2019;), 128.2/126.6 (C-9a/C-9b), 127.1 (C-6), 126.2 (C-7), 125.6 (C-8), 123.0 (C-9), 119.4 (C-3), 118.4 (C-2&#x2019;, C-6&#x2019;), 118.4/117.9 (C-1/C-3a), 78.9 (<underline>C</underline>(CH<sub>3</sub>)<sub>3</sub>), 46.9 (C-5), 32.1 (CH<sub>2</sub>), 28.1 ((CH<sub>3</sub>)<sub>3</sub>), 28.0 ((CH<sub>3</sub>)<sub>2</sub>). HRMS calcd. for C<sub>26</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub>: 416.2099. Found: 416.210.</p>
      </sec>
    </sec>
  </body>
  <back>
 <app-group>
    <app id="app1-molbank-2009-M619">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2009-M619-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2009-M619-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2009-M619-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2009-M619-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2009-M619-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2009-M619-s002-mod.mol">
   <label>Supplementary File 3</label>
</supplementary-material>
        <supplementary-material id="molbank-2009-M619-s004" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2009-M619-s002.mol">
   <label>Supplementary File 4</label>
</supplementary-material>
    </app>
</app-group>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2009-M619">
        <label>1.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Montgomery</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <source>Cancer Chemotherapeutic Agents, ACS Professional Reference Book</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Foye</surname>
              <given-names>W.O.</given-names>
            </name>
          </person-group>
          <publisher-name>American Chemical Society</publisher-name>
          <publisher-loc>Washington, DC, WA, USA</publisher-loc>
          <year>1995</year>
          <fpage>111</fpage>
          <lpage>121</lpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2009-M619">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pongprom</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Carbinol derivatives of azanaphthoquinone annelated pyrrols</article-title>
          <source>Monatsh. Chem.</source>
          <year>2009</year>
          <volume>140</volume>
          <fpage>309</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-008-0024-3</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2009-M619">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shanab</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pongprom</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Wulz</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Aicher</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>G&#xFC;nther</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>6091</fpage>
          <lpage>6095</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2007.09.054</pub-id>
          <pub-id pub-id-type="pmid">17904839</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2009-M619">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Dual function antitumor agents based on bioreduction and DNA-alkylation</article-title>
          <source>Monatsh. Chem.</source>
          <year>2007</year>
          <volume>138</volume>
          <fpage>517</fpage>
          <lpage>522</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-007-0604-7</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2009-M619">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sotelo</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>1,5-Dimethyl-6<italic>H</italic>-pyridazino[4,5-b]carbazole, a 3-aza bioisoster of the antitumor alkaloid olivacine</article-title>
          <source>Chem. Pharm. Bull.</source>
          <year>2002</year>
          <volume>50</volume>
          <fpage>1479</fpage>
          <lpage>1483</lpage>
          <pub-id pub-id-type="doi">10.1248/cpb.50.1479</pub-id>
          <pub-id pub-id-type="pmid">12419913</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2009-M619">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kabicher</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>K&#xE4;ferb&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Plenk</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and <italic>in-vitro</italic> antitumor activity of 1-[3-(indol-1-yl)prop-1-yn-1-yl]phthalazines and related compounds</article-title>
          <source>Molecules</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>1900</fpage>
          <lpage>1909</lpage>
          <pub-id pub-id-type="doi">10.3390/12081900</pub-id>
          <pub-id pub-id-type="pmid">17960095</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2009-M619">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jbara</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>K&#xE4;ferb&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Traar</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of tetra- and pentacyclic carbazole-fused imides as potential antitumor agents</article-title>
          <source>Arkivoc</source>
          <year>2009</year>
          <fpage>38</fpage>
          <lpage>47</lpage>
        </citation>
      </ref>
      <ref id="B8-molbank-2009-M619">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pichler</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kogard</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tschetschkowitsch</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Heinze</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shabaz</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and NMR-investigation of annelated pyrrole derivatives</article-title>
          <source>Heterocycles</source>
          <year>1997</year>
          <volume>45</volume>
          <fpage>1989</fpage>
          <lpage>1997</lpage>
          <pub-id pub-id-type="doi">10.3987/COM-97-7877</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2009-M619">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>F&#xFC;lep</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-substituted 5,5-dimethyl-2,5-dihydro-4<italic>H</italic>-isoindol-4-ones: Synthesis and NMR-investigation</article-title>
          <source>Heterocycles</source>
          <year>1996</year>
          <volume>43</volume>
          <fpage>1911</fpage>
          <lpage>1922</lpage>
          <pub-id pub-id-type="doi">10.3987/COM-96-7510</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2009-M619">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sukata</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-Alkylation of pyrrole, indole, and several other nitrogen heterocycles using potassium hydroxide as a base in the presence of polyethylene glycols or their dialkyl ethers</article-title>
          <source>Bull. Chem. Soc. Jpn.</source>
          <year>1983</year>
          <volume>56</volume>
          <fpage>280</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="doi">10.1246/bcsj.56.280</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2009-M619">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jorapur</surname>
              <given-names>Y.R.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Chi</surname>
              <given-names>D.Y.</given-names>
            </name>
          </person-group>
          <article-title>Mono- and dialkylations of pyrrole at C2 and C5 positions by nucleophilic substitution reaction in ionic liquid</article-title>
          <source>Org. Lett.</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>1231</fpage>
          <lpage>1234</lpage>
          <pub-id pub-id-type="doi">10.1021/ol047446v</pub-id>
          <pub-id pub-id-type="pmid">15787474</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2009-M619">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jorapur</surname>
              <given-names>Y.R.</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Chi</surname>
              <given-names>D.Y.</given-names>
            </name>
          </person-group>
          <article-title>Potassium carbonate as a base for the <italic>N</italic>-alkylation of indole and pyrrole in ionic liquids</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>2435</fpage>
          <lpage>2438</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2006.01.129</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
